|
Inhibition effects of all trans-retinoic acid on the growth and angiogenesis of esophageal squamous cell carcinoma in nude mice
|
27 September 2017 |
|
1,25(OH)2D3 Deficiency Induces Colon Inflammation via Secretion of Senescence-Associated Inflammatory Cytokines
|
27 September 2017 |
|
1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model
|
26 September 2017 |
|
Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study
|
22 September 2017 |
|
Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors
|
22 September 2017 |
|
1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
|
21 September 2017 |
|
Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
|
21 September 2017 |
|
Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro
|
20 September 2017 |
|
Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors
|
15 September 2017 |
|
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
|
15 September 2017 |